Statistically significant alteration in the lipid profile (increased TC, TG, VLDL-C, LDL-C, and Apo B) was observed in T2DM patients with and without DR (group II and group III) compared to healthy controls (group I). The gene discussed is APOB; the disease is type 2 diabetes mellitus.